These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1069 related articles for article (PubMed ID: 16480790)

  • 1. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
    Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
    Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial protection induced by a BHV-1 recombinant vaccine against challenge with BHV-5.
    Spilki FR; Silva AD; Hübner S; Esteves PA; Franco AC; Driemeier D; Roehe PM
    Ann N Y Acad Sci; 2004 Oct; 1026():247-50. PubMed ID: 15604501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BHV-1 vaccine induces cross-protection against BHV-5 disease in cattle.
    Del Médico Zajac MP; Puntel M; Zamorano PI; Sadir AM; Romera SA
    Res Vet Sci; 2006 Dec; 81(3):327-34. PubMed ID: 16540133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization against bovine herpesvirus-1 infection. Preliminary tests in calves with a DNA vaccine.
    Castrucci G; Ferrari M; Marchini C; Salvatori D; Provinciali M; Tosini A; Petrini S; Sardonini Q; Lo Dico M; Frigeri F; Amici A
    Comp Immunol Microbiol Infect Dis; 2004 May; 27(3):171-9. PubMed ID: 15001312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination.
    Makoschey B; Beer M
    Berl Munch Tierarztl Wochenschr; 2007; 120(11-12):480-2. PubMed ID: 18085158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
    Platt R; Burdett W; Roth JA
    Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a combination viral vaccine for protection of cattle against experimental infection with field isolates of bovine herpesvirus-1.
    Ellis JA; Gow SP; Goji N; Jones C; Workman A; Henderson G; Rhodes C; Alaniz G; Meinert TR; Tucker CM
    J Am Vet Med Assoc; 2009 Sep; 235(5):563-72. PubMed ID: 19719449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a mutant bovine herpesvirus-1 (BHV-1) in post-arrival outbreaks of IBR in feedlot calves and protection with conventional vaccination.
    van Drunen Littel-van den Hurk S; Myers D; Doig PA; Karvonen B; Habermehl M; Babiuk LA; Jelinski M; Van Donkersgoed J; Schlesinger K; Rinehart C
    Can J Vet Res; 2001 Apr; 65(2):81-8. PubMed ID: 11346260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of active immunization with live bovine herpesvirus 1 vaccine by passive viral antibody.
    Patel JR; Shilleto RW
    Vaccine; 2005 Jul; 23(31):4023-8. PubMed ID: 15916839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longevity of protective immunity to experimental bovine herpesvirus-1 infection following inoculation with a combination modified-live virus vaccine in beef calves.
    Ellis J; Waldner C; Rhodes C; Ricketts V
    J Am Vet Med Assoc; 2005 Jul; 227(1):123-8. PubMed ID: 16013547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV and BRSV in experimentally infected calves.
    Salt JS; Thevasagayam SJ; Wiseman A; Peters AR
    Vet J; 2007 Nov; 174(3):616-26. PubMed ID: 17276108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
    Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
    Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a temperature-sensitive modified-live bovine herpesvirus type-1 vaccine against abortion and stillbirth in pregnant heifers.
    Cravens RL; Ellsworth MA; Sorensen CD; White AK
    J Am Vet Med Assoc; 1996 Jun; 208(12):2031-4. PubMed ID: 8707679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine.
    Kaashoek MJ; Moerman A; Madić J; Rijsewijk FA; Quak J; Gielkens AL; van Oirschot JT
    Vaccine; 1994 Apr; 12(5):439-44. PubMed ID: 8023552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine herpesvirus-1 vaccination against experimental bovine herpesvirus-1 and Pasteurella haemolytica respiratory tract infection: onset of protection.
    Jericho KW; Yates WD; Babiuk LA
    Am J Vet Res; 1982 Oct; 43(10):1776-80. PubMed ID: 6183996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production.
    Woolums AR; Siger L; Johnson S; Gallo G; Conlon J
    Vaccine; 2003 Mar; 21(11-12):1158-64. PubMed ID: 12559793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protection of seronegative and seropositive calves against respiratory disease.
    Mahan SM; Sobecki B; Johnson J; Oien NL; Meinert TR; Verhelle S; Mattern SJ; Bowersock TL; Leyh RD
    J Am Vet Med Assoc; 2016 Jun; 248(11):1280-6. PubMed ID: 27172345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant bovine herpesvirus 5 defective in thymidine kinase and glycoprotein E is immunogenic for calves and confers protection upon homologous challenge and BoHV-1 challenge.
    Anziliero D; Santos CM; Brum MC; Weiblen R; Chowdhury SI; Flores EF
    Vet Microbiol; 2011 Dec; 154(1-2):14-22. PubMed ID: 22019288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV.
    Taylor G; Rijsewijk FA; Thomas LH; Wyld SG; Gaddum RM; Cook RS; Morrison WI; Hensen E; van Oirschot JT; Keil G
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1759-67. PubMed ID: 9680140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.